The International Journal of Pharma Studies considers authorship an important part of scientific integrity and scholarly responsibility. Authorship should accurately reflect individuals who have made meaningful intellectual contributions to pharmaceutical research and the preparation of the manuscript. All authors should approve the manuscript before submission and publication and accept responsibility for their respective contributions.

Authorship Criteria

Authorship should be limited to individuals who have made substantial contributions to the research or manuscript. Such contributions may include the conception or design of the research, development of methodology, experimental design, laboratory investigation, data collection or analysis, interpretation of pharmaceutical or clinical findings, or drafting and substantial revision of the manuscript.

All authors should have the opportunity to review and approve the final version of the manuscript and agree to its submission.

Author Contributions

Authors are encouraged to provide a clear description of individual contributions where appropriate. Contributions may include conceptualization, methodology, investigation, experimental work, data curation, formal analysis, validation, visualization, writing, review and editing, supervision, and project administration.

For pharmaceutical research, contribution statements may also identify responsibilities for formulation development, analytical testing, laboratory experiments, clinical data analysis, pharmacological investigations, or other relevant research activities.

The contribution statement should accurately reflect the work performed by each author. For multi-author manuscripts, the corresponding author should ensure that the information is complete and agreed upon by all authors.

Corresponding Author

The corresponding author serves as the primary contact between the authors and the International Journal of Pharma Studies throughout submission, peer review, revision, and publication.

The corresponding author is responsible for coordinating communication with co-authors and ensuring that all authors are informed about relevant editorial communications. The corresponding author should also coordinate the submission of applicable declarations, ethical approval information, clinical trial registration details, and other required documentation where relevant.

The corresponding author does not necessarily have to be the first or senior author.

Author Order

Authors should agree on the order of authors before submission. The International Journal of Pharma Studies does not normally determine author order or assess the relative contribution of individual authors.

Any change in author order after submission should be supported by an explanation and confirmation from all affected authors and may require editorial approval.

Changes in Authorship

Requests to add, remove, or change an author after submission should be submitted to the Editorial Office with a clear explanation and confirmation from all affected authors.

The journal may request written confirmation from all authors before approving a change. Changes requested after publication may require a formal correction or other appropriate editorial action.

Contributors and Acknowledgements

Individuals who contribute to the research or manuscript but do not meet the criteria for authorship should not be listed as authors.

Where appropriate, their contributions may be recognized in the Acknowledgements section with their permission. Contributions such as routine laboratory assistance, technical support, administrative assistance, provision of materials, or financial support alone do not normally constitute authorship.

Authors should appropriately acknowledge relevant institutional support, funding agencies, laboratory facilities, and other contributions where required.

Authorship Disputes

Authors are encouraged to resolve authorship questions or disagreements among themselves before submission.

Where an authorship dispute is brought to the attention of the International Journal of Pharma Studies, the journal may request relevant information or documentation and may refer the matter to the appropriate institution or authority. Editorial consideration or publication may be suspended while the matter is being addressed.

Artificial Intelligence and Authorship

Authors remain responsible for all content submitted to the International Journal of Pharma Studies, including content prepared or assisted by AI tools. Authors should verify the accuracy of scientific statements, pharmaceutical terminology, references, experimental interpretations, analytical results, and other AI-assisted content.

Where disclosure of AI use is required under the journal's policies, authors should provide the relevant information in accordance with the applicable requirements. AI tools must not be used to fabricate research data, generate misleading experimental results, manipulate scientific images deceptively, or create inaccurate references.